Dr. Robert Durst, M.D

NPI: 1144287855
Total Payments
$454.44
2019 Payments
$42.94
Companies
12
Transactions
22

Payment Breakdown by Category

Food & Beverage$454.44 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $454.44 22 100.0%

Top Paying Companies

Company Total Records Latest Year
Sirtex Medical Inc $141.75 5 $0 (2018)
HOLOGIC INC $60.85 1 $0 (2017)
E.R. Squibb & Sons, L.L.C. $44.27 3 $0 (2018)
Kyowa Kirin, Inc. $36.70 2 $0 (2018)
Boehringer Ingelheim Pharmaceuticals, Inc. $34.95 2 $0 (2019)
AstraZeneca Pharmaceuticals LP $34.04 2 $0 (2018)
Exelixis Inc. $25.43 1 $0 (2017)
Celgene Corporation $21.15 2 $0 (2018)
Novartis Pharmaceuticals Corporation $16.92 1 $0 (2018)
Spectrum Pharmaceuticals Inc. $13.62 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2019 $42.94 3 Boehringer Ingelheim Pharmaceuticals, Inc. ($18.18)
2018 $147.58 11 E.R. Squibb & Sons, L.L.C. ($44.27)
2017 $263.92 8 Sirtex Medical Inc ($118.28)

All Payment Transactions

22 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/07/2019 Janssen Biotech, Inc. Erleada (Drug), DARZALEX Food and Beverage In-kind items and services $12.72 General
Category: Oncology
02/28/2019 Octapharma USA, Inc. OCTAPLAS (Biological) Food and Beverage In-kind items and services $12.04 General
Category: INTENSIVE CAREEMERGENCY
02/08/2019 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $18.18 General
12/13/2018 Kyowa Kirin, Inc. POTELIGEO (Drug) Food and Beverage In-kind items and services $18.35 General
Category: MONOCLONAL ANTIBODY
12/13/2018 Kyowa Kirin, Inc. POTELIGEO (Drug) Food and Beverage In-kind items and services $18.35 General
Category: MONOCLONAL ANTIBODY
11/29/2018 Celgene Corporation Abraxane (Drug) Food and Beverage In-kind items and services $10.75 General
Category: Oncology
10/25/2018 AstraZeneca Pharmaceuticals LP IMFINZI (Drug) Food and Beverage In-kind items and services $15.47 General
Category: Oncology
07/26/2018 E.R. Squibb & Sons, L.L.C. EMPLICITI (Biological) Food and Beverage Cash or cash equivalent $14.86 General
Category: Oncology
07/19/2018 Novartis Pharmaceuticals Corporation VOTRIENT (Drug) Food and Beverage In-kind items and services $16.92 General
Category: ONCOLOGY
04/26/2018 E.R. Squibb & Sons, L.L.C. EMPLICITI (Biological) Food and Beverage Cash or cash equivalent $10.54 General
Category: Oncology
03/15/2018 Sirtex Medical Inc SIR-Spheres Microspheres (Device) Food and Beverage Cash or cash equivalent $11.70 General
Category: Interventional Oncology
02/15/2018 E.R. Squibb & Sons, L.L.C. EMPLICITI (Biological) Food and Beverage Cash or cash equivalent $18.87 General
Category: Oncology
01/18/2018 Sirtex Medical Inc SIR-Spheres Microspheres (Device) Food and Beverage Cash or cash equivalent $11.15 General
Category: Interventional Oncology
01/18/2018 Sirtex Medical Inc SIR-Spheres Microspheres (Device) Food and Beverage Cash or cash equivalent $0.62 General
Category: Interventional Oncology
12/20/2017 AstraZeneca Pharmaceuticals LP TAGRISSO (Drug) Food and Beverage In-kind items and services $18.57 General
Category: Oncology
11/14/2017 HOLOGIC INC 3Dimensions (Device) Food and Beverage In-kind items and services $60.85 General
Category: Breast and Skeletal
08/31/2017 Boehringer Ingelheim Pharmaceuticals, Inc. GILOTRIF (Drug) Food and Beverage In-kind items and services $16.77 General
Category: ONCOLOGY
06/29/2017 Exelixis Inc. Cabometyx (Drug) Food and Beverage In-kind items and services $25.43 General
Category: Oncology
06/07/2017 Celgene Corporation Abraxane (Drug) Food and Beverage In-kind items and services $10.40 General
Category: Oncology
04/20/2017 Spectrum Pharmaceuticals Inc. Zevalin (Drug) Food and Beverage In-kind items and services $13.62 General
Category: Not Applicable
03/23/2017 Sirtex Medical Inc SIR-Spheres Microspheres (Device) Food and Beverage Cash or cash equivalent $106.82 General
Category: Interventional Oncology
01/19/2017 Sirtex Medical Inc SIR-Spheres Microspheres (Device) Food and Beverage Cash or cash equivalent $11.46 General
Category: Interventional Oncology

About Dr. Robert Durst, M.D

Dr. Robert Durst, M.D is a Diagnostic Radiology healthcare provider based in Rapid City, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144287855.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Durst, M.D has received a total of $454.44 in payments from pharmaceutical and medical device companies, with $42.94 received in 2019. These payments were reported across 22 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($454.44).

Practice Information

  • Specialty Diagnostic Radiology
  • Location Rapid City, SD
  • Active Since 04/27/2006
  • Last Updated 07/29/2016
  • Taxonomy Code 2085R0202X
  • Entity Type Individual
  • NPI Number 1144287855

Products in Payments

  • SIR-Spheres Microspheres (Device) $141.75
  • 3Dimensions (Device) $60.85
  • EMPLICITI (Biological) $44.27
  • POTELIGEO (Drug) $36.70
  • Cabometyx (Drug) $25.43
  • Abraxane (Drug) $21.15
  • TAGRISSO (Drug) $18.57
  • VOTRIENT (Drug) $16.92
  • GILOTRIF (Drug) $16.77
  • IMFINZI (Drug) $15.47
  • Zevalin (Drug) $13.62
  • Erleada (Drug) $12.72
  • OCTAPLAS (Biological) $12.04

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Diagnostic Radiology Doctors in Rapid City